2020新闻发布 日期 标题 10/11/2020 Beroni Group Launches a New Probiotics Health Product in China 09/11/2020 Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020 19/10/2020 Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19 08/09/2020 Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan 12/08/2020 Beroni Signs Agreement with Genscript Biotech 04/08/2020 Beroni Constructed Nanobodies for Coronavirus 10/07/2020 Beroni to Supply COVID-19 Antibody Test Kit to Japan 30/06/2020 Dr Richard Buchta Appointed as Director of Beroni Group 27/05/2020 Issue of US$2.97m Convertible Notes to Fund Growth 08/05/2020 Beroni Identifies 24 Types of Nanobodies for COVID-19 03/04/2020 CE Certification Received for Covid-19 Test Kit 03/04/2020 Beroni Notifies FDA of Validated COVID19 Serology Test 26/03/2020 Submission of COVID-19 Rapid Test Kit to US FDA 09/03/2020 Beroni Advances R&D of Medical Solution for COVID-19 20/02/2020 Beroni to Develop Novel Solution for Coronavirus 12/02/2020 Beroni Featured in New Research Initiation Report 14/01/2020 Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco 13/01/2020 Beroni Group to Present at Biotech Showcase™ 2020 in San Francisco
